Pt Phapros Tbk
PT Phapros Tbk, a prominent player in Indonesia's pharmaceutical industry, is headquartered in Semarang, Central Java. Established in 1971, the company has evolved significantly, marking key milestones in its commitment to healthcare innovation and quality. Specialising in the production of generic medicines, over-the-counter products, and herbal supplements, PT Phapros Tbk distinguishes itself through rigorous quality control and a diverse product portfolio. The company serves various regions across Indonesia, ensuring accessibility to essential healthcare solutions. With a strong market position, PT Phapros Tbk has garnered recognition for its contributions to public health, making it a trusted name in the pharmaceutical sector. Its dedication to research and development continues to drive its growth and enhance its reputation within the industry.
DitchCarbon Score
How does Pt Phapros Tbk's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Pt Phapros Tbk's score of 17 is lower than 88% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Pt Phapros Tbk's reported carbon emissions
In 2023, PT Phapros Tbk reported total global emissions of approximately 3,000 kg CO2e. However, specific emissions data for their operations in Indonesia (ID) was not disclosed for this year. The company has not provided detailed figures for Scope 1, Scope 2, or Scope 3 emissions, indicating a lack of comprehensive emissions reporting. In 2022, the company disclosed Scope 1 emissions of about 550 kg CO2e and Scope 2 emissions from purchased electricity amounting to approximately 10,168,000 kg CO2e. This indicates a significant reliance on electricity, contributing to their overall carbon footprint. Despite the absence of specific reduction targets or initiatives, PT Phapros Tbk is part of a corporate family relationship with PT Kimia Farma Tbk, which may influence their sustainability practices. However, no specific climate commitments or reduction targets have been reported, suggesting that the company may need to enhance its climate strategy to align with industry standards. Overall, while PT Phapros Tbk has begun to report emissions, there is a clear opportunity for improvement in transparency and commitment to carbon reduction initiatives.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2020 | 2021 | 2022 | |
|---|---|---|---|
| Scope 1 | 0.82 | 0.0 | 0.00 |
| Scope 2 | - | 0,000,000 | 00,000,000 |
| Scope 3 | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Pt Phapros Tbk is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
